Odence-Ford Marion — SEC insider filings

SEC reporting owner CIK 1845002. 30 insider filings on record with FilingPulse; latest filed 2026-08-24.

Transaction summary — filings shown

Covers all 30 filings on record, filed 2021-02-12 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
OptimizeRx Corp (OPRX)Chief Legal & Admin Officer301 leg · 1,000 sh · $15,7501 leg · 4,000 sh · $60,75165

Insider filings — Odence-Ford Marion

FiledFormIssuerReported transactionsSource
2026-08-244OptimizeRx Corp (OPRX)Tax withholding (F): 1,529 @ $7.71EDGAR
2026-08-244OptimizeRx Corp (OPRX)Grant/award (A): 57,600 @ $0EDGAR
2026-02-134OptimizeRx Corp (OPRX)Option exercise (M): 4,000 · Tax withholding (F): 1,386 @ $9.23 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2025-12-234OptimizeRx Corp (OPRX)Tax withholding (F): 4,051 @ $12.74EDGAR
2025-12-224OptimizeRx Corp (OPRX)Option exercise (M): 3,928 @ $0 · Tax withholding (F): 1,153 @ $13.51 · Option exercise (M): 3,928 (derivative) @ $0EDGAR
2025-10-074OptimizeRx Corp (OPRX)Option exercise (M): 6,649 @ $0 · Tax withholding (F): 1,952 @ $18.75 · Option exercise (M): 6,649 (derivative) @ $0EDGAR
2025-08-254OptimizeRx Corp (OPRX)Grant/award (A): 15,625 @ $0 · Grant/award (A): 35,156 (derivative) @ $0EDGAR
2025-03-044OptimizeRx Corp (OPRX)Option exercise (M): 771 @ $0 · Tax withholding (F): 268 @ $5.18 · Option exercise (M): 771 (derivative) @ $0EDGAR
2025-02-204OptimizeRx Corp (OPRX)Tax withholding (F): 1,479 @ $6.64EDGAR
2025-02-134OptimizeRx Corp (OPRX)Option exercise (M): 4,000 · Tax withholding (F): 1,386 @ $5.60 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2024-12-274OptimizeRx Corp (OPRX)Grant/award (A): 41,408 @ $0 · Grant/award (A): 77,742 (derivative) @ $0EDGAR
2024-12-204OptimizeRx Corp (OPRX)Option exercise (M): 3,927 @ $0 · Tax withholding (F): 1,153 @ $4.75 · Option exercise (M): 3,927 (derivative) @ $0EDGAR
2024-11-124OptimizeRx Corp (OPRX)Option exercise (M): 1,785 @ $0 · Tax withholding (F): 524 @ $6.27 · Option exercise (M): 1,785 (derivative) @ $0EDGAR
2024-10-074OptimizeRx Corp (OPRX)Option exercise (M): 6,649 @ $0 · Tax withholding (F): 1,952 @ $7.83 · Option exercise (M): 6,649 (derivative) @ $0EDGAR
2024-04-244OptimizeRx Corp (OPRX)Grant/award (A): 4,267 @ $0EDGAR
2024-03-064OptimizeRx Corp (OPRX)Option exercise (M): 771 @ $0 · Tax withholding (F): 268 @ $15.95 · Option exercise (M): 771 (derivative) @ $0EDGAR
2024-02-214OptimizeRx Corp (OPRX)Grant/award (A): 11,783 (derivative) @ $0 · Grant/award (A): 11,783 (derivative) @ $0EDGAR
2024-02-134OptimizeRx Corp (OPRX)Option exercise (M): 4,000 @ $0 · Tax withholding (F): 1,386 @ $15.39 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2024-01-114OptimizeRx Corp (OPRX)Sale (S): 4,000 @ $15.19EDGAR
2023-11-134OptimizeRx Corp (OPRX)Option exercise (M): 1,785 @ $0 · Tax withholding (F): 524 @ $9.21 · Option exercise (M): 1,785 (derivative) @ $0EDGAR
2023-10-064OptimizeRx Corp (OPRX)Option exercise (M): 6,649 @ $0 · Tax withholding (F): 1,952 @ $7.06 · Option exercise (M): 6,649 (derivative) @ $0EDGAR
2023-03-034OptimizeRx Corp (OPRX)Option exercise (M): 771 @ $0 · Tax withholding (F): 268 @ $18.11 · Option exercise (M): 771 (derivative) @ $0EDGAR
2023-02-144OptimizeRx Corp (OPRX)Option exercise (M): 4,000 @ $0 · Tax withholding (F): 1,422 @ $17.34 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2022-11-104OptimizeRx Corp (OPRX)Option exercise (M): 1,785 @ $0 · Tax withholding (F): 710 @ $14.52 · Option exercise (M): 1,785 (derivative) @ $0EDGAR
2022-10-054OptimizeRx Corp (OPRX)Grant/award (A): 19,947 (derivative) @ $0 · Grant/award (A): 39,055 (derivative) @ $0EDGAR
2022-08-304OptimizeRx Corp (OPRX)Purchase (P): 1,000 @ $15.75EDGAR
2022-03-034OptimizeRx Corp (OPRX)Grant/award (A): 4,690 (derivative) @ $0 · Grant/award (A): 2,313 (derivative) @ $0EDGAR
2022-02-154OptimizeRx Corp (OPRX)Option exercise (M): 4,000 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2021-11-104OptimizeRx Corp (OPRX)Grant/award (A): 10,958 (derivative) @ $0 · Grant/award (A): 5,355 (derivative) @ $0EDGAR
2021-02-124OptimizeRx Corp (OPRX)Grant/award (A): 20,000 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-02-12 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1845002 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs